Cargando…
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345846/ https://www.ncbi.nlm.nih.gov/pubmed/36877766 http://dx.doi.org/10.1182/bloodadvances.2022009548 |
| _version_ | 1785073181068886016 |
|---|---|
| author | Schieber, Timothy Li, Anthony Lundberg, Jordan Wiczer, Tracy Voorhees, Timothy |
| author_facet | Schieber, Timothy Li, Anthony Lundberg, Jordan Wiczer, Tracy Voorhees, Timothy |
| author_sort | Schieber, Timothy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10345846 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103458462023-07-15 Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders Schieber, Timothy Li, Anthony Lundberg, Jordan Wiczer, Tracy Voorhees, Timothy Blood Adv Research Letter The American Society of Hematology 2023-03-07 /pmc/articles/PMC10345846/ /pubmed/36877766 http://dx.doi.org/10.1182/bloodadvances.2022009548 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Schieber, Timothy Li, Anthony Lundberg, Jordan Wiczer, Tracy Voorhees, Timothy Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title | Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title_full | Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title_fullStr | Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title_full_unstemmed | Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title_short | Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| title_sort | successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345846/ https://www.ncbi.nlm.nih.gov/pubmed/36877766 http://dx.doi.org/10.1182/bloodadvances.2022009548 |
| work_keys_str_mv | AT schiebertimothy successfulobinutuzumabadministrationafterrituximabdiscontinuationduetointoleranceinpatientswithhematologicdisorders AT lianthony successfulobinutuzumabadministrationafterrituximabdiscontinuationduetointoleranceinpatientswithhematologicdisorders AT lundbergjordan successfulobinutuzumabadministrationafterrituximabdiscontinuationduetointoleranceinpatientswithhematologicdisorders AT wiczertracy successfulobinutuzumabadministrationafterrituximabdiscontinuationduetointoleranceinpatientswithhematologicdisorders AT voorheestimothy successfulobinutuzumabadministrationafterrituximabdiscontinuationduetointoleranceinpatientswithhematologicdisorders |